DRW Securities’s Inozyme Pharma INZY Stock Holding History

DRW Securities’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,178	Closed	-$40.7K	–	1458
2025 Q2	$40.7K	Buy	+10,178	New	+$25.2K	﹤0.01%	1042

DRW Securities's INZY Position: Q3 2025 in Review

DRW Securities sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 10,178 shares — an estimated $40.7K sold.

DRW Securities first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $40.7K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

DRW Securities reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
DRW Securities sold 10,178 Inozyme Pharma shares in Q3 2025, an estimated $40.7K.
DRW Securities first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
DRW Securities's Inozyme Pharma position peaked at $40.7K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on DRW Securities's 13F filing for Q3 2025, filed 14 Nov 2025.